PW06 - TB Workshop ($)

Sunday, October 19, 2025

8:00 AM - 12:00 PM US ET

Location: B314

CME Credits: Maximum of 4 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 4 hours of MOC Credit
CNE Credits: Maximum of 4 hours of ANCC Credit
ACPE Credits: ACPE 4 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 4 of PACE contact hours
CE Broker: Maximum of 4 CE broker credit hours

Workshop Moderator(s)

Yukari Manabe, MD, FIDSA, FRCP (she/her/hers)

Professor
Johns Hopkins University School of Medicine
Baltimore, MD, United States
Maunank Shah, MD, PhD

Associate Professor
Johns Hopkins
Baltimore, MD, United States
Caitlin Reed, MD, MPH

Medical Team Lead, Division of TB Elimination
Centers for Disease Control and Prevention
Atlanta, Georgia, United States

Faculty(s)

Alexander Schmidt, MD PhD (he/him/his)

Head of Development & Chief Medical Officer
Gates Medical Research Institute
Cambridge, MA, United States
CH

Connie Haley
Francesca Lee, MD

Associate Professor
Department of Pathology and Medicine, Division of Infectious Diseases and Geographic Medicine
University of Texas Southwestern
Dallas, TX, United States
Janice Louie, Doctor of Medicine, Master of Public Health (she/her/hers)

Medical Director
San Francisco Department of Public Health
Oakland, California, United States
Jason Cummins, MPH

Program Director
Tennessee Department of Health, TB Elimination Program
Nashville, TN, United States
Kenneth (Ken) Castro, MD, FIDSA (he/him/his)

Co-Director, Emory TB center & Professor of Global Health, Epidemiology, and Infectious Diseases
Rollins School of Public Health & School of Medicine, Emory University
Kelly Dooley, MD PhD MPH

Director, Division of Infectious Diseases
Vanderbilt University Medical Center
Kendall Martinez-Wright (she/her/hers)

Government Relations and Policy Associate
Treatmentactiongroup
Washington, DC, United States
Marcos Coutinho Schechter, MD

Associate Professor
Emory University
Sara Hoopchuk, MS (she/her/hers)

Public Policy Manager
IDSA

Disclosure(s):

Yukari C. Manabe, MD, FIDSA, FRCP: Cepheid, Inc: Grant/Research Support; Chembio: Grant/Research Support; Hologic Inc: Grant/Research Support; Roche Diagnostics: Grant/Research Support

Maunank Shah, MD, PhD: Scene Health: license

Caitlin Reed, MD, MPH: No financial relationships to disclose.

Alexander Schmidt, MD PhD: No financial relationships to disclose.

Francesca Lee, MD: No financial relationships to disclose.

Janice Louie, Doctor of Medicine, Master of Public Health: No financial relationships to disclose.

Jason Cummins, MPH: No financial relationships to disclose.

Kenneth (Ken) G. Castro, MD, FIDSA: No financial relationships to disclose.

Kelly Dooley, MD PhD MPH: No financial relationships to disclose.

Kendall Martinez-Wright: No financial relationships to disclose.

Marcos Coutinho Schechter, MD: No financial relationships to disclose.

Sara Hoopchuk, MS: No financial relationships to disclose.

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the latest updates in research and development of new TB products;
describe updates on TB control efforts in the U.S. and globally in light of changes in the global health policy and funding landscape;
apply the latest evidence-based strategies for management of TB infection;
describe effective advocacy techniques to advance TB-related policies;

Presentations:

8:00 AM - 8:10 AM US ET

Opening Remarks
Workshop Speaker: Yukari C. Manabe, MD, FIDSA, FRCP (she/her/hers) – Johns Hopkins University School of Medicine
8:10 AM - 8:30 AM US ET

State of TB in the U.S.: Impacts of Federal Actions on the Domestic TB Response
Workshop Speaker: Jason Cummins, MPH – Tennessee Department of Health, TB Elimination Program
8:30 AM - 8:50 AM US ET

State of TB Globally: Impacts of Federal Actions on the Global TB Response
Workshop Speaker: Kendall Martinez-Wright (she/her/hers) – Treatmentactiongroup
8:50 AM - 9:05 AM US ET

Update on LDTs
Workshop Speaker: Francesca Lee, MD – University of Texas Southwestern
9:05 AM - 9:20 AM US ET

Advocacy in Action: LDT Outcome
Workshop Speaker: Sara Hoopchuk, MS (she/her/hers) – IDSA
9:20 AM - 9:40 AM US ET

Latest on TB Vaccine Development
Workshop Speaker: Alexander Schmidt, MD PhD (he/him/his) – Gates Medical Research Institute
10:00 AM - 10:20 AM US ET

A 2025 Look at U.S. TB Clinical Guidelines
Workshop Speaker: Maunank Shah, MD, PhD – Johns Hopkins
10:20 AM - 10:40 AM US ET

New TB Drugs in the Pipeline
Workshop Speaker: Kelly Dooley, MD PhD MPH – Vanderbilt University Medical Center
10:40 AM - 11:55 AM US ET

Panel Discussion: Implementing new evidence into the management of TB
Workshop Speaker: Maunank Shah, MD, PhD – Johns Hopkins
Workshop Speaker: Caitlin Reed, MD, MPH – Centers for Disease Control and Prevention
Workshop Speaker: Janice Louie, Doctor of Medicine, Master of Public Health (she/her/hers) – San Francisco Department of Public Health
Workshop Speaker: Connie Haley
Workshop Speaker: Marcos Coutinho Schechter, MD – Emory University
11:55 AM - 12:00 PM US ET

Closing Remarks
Workshop Speaker: Kenneth (Ken) G. Castro, MD, FIDSA (he/him/his) – Rollins School of Public Health & School of Medicine, Emory University